Expert Opinion on Biological Therapy This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Analytical comparability demonstrated for an IgG4 molecule, inclacumab, following transfer of manufacturing responsibility from Roche to Global Blood Therapeutics
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 9, 2022 Category: Drugs & Pharmacology Authors: Radu Mihaila Dipali Ruhela Lifang Xu Sandra Joussef Xin Geng Jianxia Shi Andrea S. Kim Wendy Yares Kevin Furstoss Kent Iverson Source Type: research

Locked and loaded: engineering and arming oncolytic adenoviruses to enhance anti-tumor immune responses
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 9, 2022 Category: Drugs & Pharmacology Authors: Shao-Chia Lu Michael A Barry Source Type: research

Cell homing strategy as a promising approach to the vitality of pulp-dentin complexes in endodontic therapy: focus on potential biomaterials
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 8, 2022 Category: Drugs & Pharmacology Authors: Elaheh Dalir Abdolahinia Zahra Safari Sayed Soroush Sadat Kachouei Ramin Zabeti Jahromi Nastaran Atashkar Amirreza Karbalaeihasanesfahani Mahdieh Alipour Nastaran Hashemzadeh Simin Sharifi Solmaz Maleki Dizaj Source Type: research

Sargramostim in acute radiation syndrome
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 7, 2022 Category: Drugs & Pharmacology Authors: Hillard M Lazarus John McManus Robert Peter Gale Source Type: research

Antibody therapeutics for epithelial ovarian cancer
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 5, 2022 Category: Drugs & Pharmacology Authors: Mason Ruiz Ningyan Zhang Anil K Sood Zhiqiang An Source Type: research

The ULTIMATE trials: are there advantages of ublituximab over teriflunomide in relapsing multiple sclerosis?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 4, 2022 Category: Drugs & Pharmacology Authors: Sheila A Doggrell Source Type: research

Anti-IL 23 biologics for the treatment of plaque psoriasis
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 27, 2022 Category: Drugs & Pharmacology Authors: Alan Vu Caden Ulschmid Kenneth B. Gordon Source Type: research

Assessment of real-life patient handling experience of AVT02 administered subcutaneously via autoinjector in patients with moderate to severe active rheumatoid arthritis: an open-label, single-arm clinical trial, then an extension phase of AVT02 administered with a prefilled syringe
Volume 23, Issue 8, July - December 2023 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 26, 2022 Category: Drugs & Pharmacology Authors: Nemanja DamjanovNana KirvalidzeNana KurashviliFausto BertiMatjaz SteigerJoanna SobierskaEric GuenziHendrik OttoAbid SattarHalimu N. HaliduolaElin EdwaldHeimo Stroissniga School of Medicine, University of Belgrade, Belgrade, Serbiab Department of Traumatol Source Type: research

Assessment of real-life patient handling experience of AVT02 administered subcutaneously via autoinjector in patients with moderate to severe active rheumatoid arthritis: an open-label, single-arm clinical trial, then an extension phase of AVT02 administered with a prefilled syringe
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 26, 2022 Category: Drugs & Pharmacology Authors: Nemanja Damjanov Nana Kirvalidze Nana Kurashvili Fausto Berti Matjaz Steiger Joanna Sobierska Eric Guenzi Hendrik Otto Abid Sattar Halimu N. Haliduola Elin Edwald Heimo Stroissnig Source Type: research

Pembrolizumab: first anti-PD-1/L1-based regimen for first-line treatment of advanced esophageal cancer in Japan
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 21, 2022 Category: Drugs & Pharmacology Authors: Kentaro Harada Shun Yamamoto Ken Kato Source Type: research

Original antigen sin and COVID-19: implications for seasonal vaccination
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 19, 2022 Category: Drugs & Pharmacology Authors: Matthew W. McCarthy Source Type: research

Effect of biological DMARDs and JAK inhibitors in pain of chronic inflammatory arthritis
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 15, 2022 Category: Drugs & Pharmacology Authors: Alessandra Alciati Marco Di Carlo Cesare Siragusano Antonino Palumbo Ignazio Francesco Masala Fabiola Atzeni Source Type: research

A multicenter, randomized, open-label, 2-arm parallel study to compare the pharmacokinetics, safety and tolerability of AVT02 administered subcutaneously via prefilled syringe or autoinjector in healthy adults
Volume 23, Issue 8, July - December 2023 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 6, 2022 Category: Drugs & Pharmacology Authors: Christopher WynneChristian SchwabeHeimo StroissnigRoshan DiasJoanna SobierskaEric GuenziHendrik OttoAbid SattarHalimu N HaliduolaElin EdwaldFausto Bertia Biosimilar Trials, New Zealand Clinical Research, Christchurch, New Zealandb Biosimilar Trials, New Z Source Type: research

A multicenter, randomized, open-label, 2-arm parallel study to compare the pharmacokinetics, safety and tolerability of AVT02 administered subcutaneously via prefilled syringe or autoinjector in healthy adults
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 6, 2022 Category: Drugs & Pharmacology Authors: Christopher Wynne Christian Schwabe Heimo Stroissnig Roshan Dias Joanna Sobierska Eric Guenzi Hendrik Otto Abid Sattar Halimu N Haliduola Elin Edwald Fausto Berti Source Type: research

Biological treatment for erythrodermic psoriasis
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - September 28, 2022 Category: Drugs & Pharmacology Authors: Sunil Dogra Hitaishi Mehta Source Type: research